Miransertib hydrochloride
Miransertib hydrochloride is an orally bioavailable, allosteric pan-Akt inhibitor targeting AKT1/2/3. It is used in research for PI3K/Akt pathway-related cancers, leishmaniasis, and Proteus syndrome, with studies demonstrating its efficacy in both cellular and animal models.
Product Specifications
CAS Number
1313883-00-9
Product Name Alternative
Miransertib (ARQ 092) HCl, ARQ-092 hydrochloride
Field of Research
Infectious Disease & Virology, Signal Transduction
Purity
99.81% (May vary between batches)
Solubility
DMSO:40 mg/mL (85.29 mM) ;10% DMSO+90% Saline:2 mg/mL (4.26 mM)
Smiles
Cl.Nc1ncccc1-c1nc2ccc (nc2n1-c1ccc (cc1) C1 (N) CCC1) -c1ccccc1
Molecular Formula
C27H25ClN6
Molecular Weight
468.98
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog